archive-fr.com » FR » I » IT-INITIATIVE.FR

Total: 133

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Criteria
    Press release Contact Plan You are here Home News inserm Criteria News Press release Partners News Page à supprimer магазин DVD фильмов Battlefield 4 Beta обзоры тесты новости Home About us Our history Investors Partners Investment Investment Strategy Investment Process

    Original URL path: http://www.it-initiative.fr/news/78-inserm/82-criteria?style=blue (2015-10-11)
    Open archived version from archive


  • News
    Quai du Sartel 59100 Roubaix 0899 701 761 Website developement by the ML COM Communication Agency Under the Loi Informatique et Libertés du 06 01 78 you have a right to access modify correct or delete personal information To exercise this right simply write at the following address Paris BioPark 7 Rue Watt 75013 Paris 01 55 03 01 00 Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=green&limitstart=0 (2015-10-11)
    Open archived version from archive

  • News
    Quai du Sartel 59100 Roubaix 0899 701 761 Website developement by the ML COM Communication Agency Under the Loi Informatique et Libertés du 06 01 78 you have a right to access modify correct or delete personal information To exercise this right simply write at the following address Paris BioPark 7 Rue Watt 75013 Paris 01 55 03 01 00 Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=red&limitstart=0 (2015-10-11)
    Open archived version from archive

  • News
    Quai du Sartel 59100 Roubaix 0899 701 761 Website developement by the ML COM Communication Agency Under the Loi Informatique et Libertés du 06 01 78 you have a right to access modify correct or delete personal information To exercise this right simply write at the following address Paris BioPark 7 Rue Watt 75013 Paris 01 55 03 01 00 Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=orange&limitstart=0 (2015-10-11)
    Open archived version from archive

  • News
    Quai du Sartel 59100 Roubaix 0899 701 761 Website developement by the ML COM Communication Agency Under the Loi Informatique et Libertés du 06 01 78 you have a right to access modify correct or delete personal information To exercise this right simply write at the following address Paris BioPark 7 Rue Watt 75013 Paris 01 55 03 01 00 Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=blue&limitstart=0 (2015-10-11)
    Open archived version from archive